Evidence map›Paper›PMID 40380191›Full record

ArticleBMC veterinary research2025

Correction: Efficacy and mechanism of action of harmine derivative H-2-104 against Echinococcus granulosus infection in mice.

Huijing Gao, Qinwei Xu, Jiang Zhu, Kadierya Kuerban, Bei Chen, Jun Zhao, Kalibixiati Aimulajiang, Liang Teng

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Huijing Gao *Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Qinwei Xu *Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Jiang Zhu *State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, 830000, China.
Kadierya KuerbanDepartment of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Bei ChenDepartment of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Jun ZhaoDepartment of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Kalibixiati AimulajiangState Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, 830000, China. kali0920@163.com.
Liang TengDepartment of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China. tl750212@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40380191
PMCPMC12083123

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.